| Date Filed | Type | Description |
| 08/15/2023 |
4
| McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Sold 28,975 shares
@ $14.9306, valued at
$432.6k
|
|
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Granted 33,000 options to buy
@ $14.1, valued at
$465.3k
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| McCamish Mark Anthony (Director) has filed a Form 4 on Rafael Holdings, Inc.|
Txns:
| Granted 5,412 shares
@ $5.39, valued at
$29.2k
|
|
| 08/05/2021 |
4
| McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Granted 42,000 options to buy
@ $8.07, valued at
$338.9k
|
|
| 06/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/28/2020 |
4
| McCamish Mark Anthony (Director) has filed a Form 4 on Vincera Pharma, Inc.|
Txns:
| Granted 6,667 options to buy
@ $19, valued at
$126.7k
|
|
| 12/28/2020 |
3
| McCamish Mark Anthony (Director) has filed a Form 3 on Vincera Pharma, Inc. |
| 09/18/2020 |
4
| McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Bought 118,602 shares
@ $5.7332, valued at
$680k
Bought 52,398 shares
@ $5.8256, valued at
$305.2k
|
|
| 09/14/2020 |
4
| McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Granted 50,000 options to buy
@ $5.3, valued at
$265k
|
|
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2020 |
4
| McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Disposed/sold 4,595 shares
@ $0
Disposed/sold 314,395 options to buy
@ $4.8825, valued at
$1.5M
Disposed/sold 134,629 options to buy
@ $4.8825, valued at
$657.3k
Disposed/sold 334,239 options to buy
@ $5.27, valued at
$1.8M
Disposed/sold 184,516 options to buy
@ $8.7575, valued at
$1.6M
Disposed/sold 327,375 options to buy
@ $35.75, valued at
$11.7M
|
|
| 04/03/2020 |
4
| McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Gifted 60,719 shares
@ $0
Sold 2,340 shares
@ $95.4138, valued at
$223.3k
Sold 30,237 shares
@ $95.4207, valued at
$2.9M
Exercised 30,210 options to buy
@ $4.8825, valued at
$147.5k
Exercised 27 options to buy
@ $4.8825, valued at
$131.8 |
|
| 12/17/2019 |
4
| McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Granted 327,375 options to buy
@ $35.75, valued at
$11.7M
|
|
| 12/09/2019 |
4
| McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Granted 60,000 options to buy
@ $5.92, valued at
$355.2k
|
|
| 12/09/2019 |
3
| McCamish Mark Anthony (Director) has filed a Form 3 on AVADEL PHARMACEUTICALS PLC |
| 06/27/2019 |
4
| McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Sold 8,199 shares
@ $11.0246, valued at
$90.4k
Exercised 8,199 options to buy
@ $4.8825, valued at
$40k
|
|
| 06/24/2019 |
4
| McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Sold 8,301 shares
@ $11.038, valued at
$91.6k
Exercised 8,301 options to buy
@ $4.8825, valued at
$40.5k
|
|
| 05/22/2019 |
4
| McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Sold 15,209 shares
@ $12.0748, valued at
$183.6k
Sold 1,291 shares
@ $12.4555, valued at
$16.1k
Exercised 15,209 options to buy
@ $4.8825, valued at
$74.3k
Exercised 1,291 options to buy
@ $4.8825, valued at
$6.3k
|
|
| 04/22/2019 |
4
| McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Sold 16,500 shares
@ $18.1245, valued at
$299.1k
Exercised 16,500 options to buy
@ $4.8825, valued at
$80.6k
|
|
| 03/21/2019 |
4
| McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Sold 16,500 shares
@ $18.1455, valued at
$299.4k
Exercised 16,500 options to buy
@ $4.8825, valued at
$80.6k
|
|
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
4
| McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Sold 20,000 shares
@ $14.5946, valued at
$291.9k
Exercised 16,500 options to buy
@ $4.8825, valued at
$80.6k
Exercised 3,500 options to buy
@ $4.8825, valued at
$17.1k
|
|
| 12/28/2018 |
4
| McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Sold 9,032 shares
@ $15.9041, valued at
$143.6k
Sold 2,968 shares
@ $15.8895, valued at
$47.2k
Exercised 9,032 options to buy
@ $4.8825, valued at
$44.1k
Exercised 2,968 options to buy
@ $4.8825, valued at
$14.5k
|
|
| 06/27/2018 |
3
| McCamish Mark Anthony (President and CEO) has filed a Form 3 on Forty Seven, Inc. |
| 04/06/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/23/2009 |
4
| McCamish Mark Anthony (Sr. VP & Chief Medical Officer) has filed a Form 4 on FACET BIOTECH CORP |
| 01/27/2009 |
4
| McCamish Mark Anthony (Sr. VP & Chief Medical Officer) has filed a Form 4 on FACET BIOTECH CORP |
| 12/19/2008 |
3
| McCamish Mark Anthony (Sr. VP & Chief Medical Officer) has filed a Form 3 on FACET BIOTECH CORP |
| 12/19/2008 |
4
| McCamish Mark Anthony (SVP & CMO) has filed a Form 4 on PDL BIOPHARMA, INC. |